Belgium· BE-AMP-SAM193995-00
Infanrix Hib 0,5 ml/dose
A haemophilus influenzae b, kombinationen mit toxoiden product containing bordetella pertussis filamentous hemagglutinin (fha), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Haemophilus influenzae b, kombinationen mit toxoiden is registered in 2 of 19 countries.
Countries holding a registration under ATC J07AG51 (haemophilus influenzae b, kombinationen mit toxoiden), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 1 of them publish a price we can compare per daily dose
Haemophilus influenzae b, kombinationen mit toxoiden · ATC J07AG51
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Bordetella Pertussis Filamentous Hemagglutinin (FHA)
- Manufacturer
- GlaxoSmithKline Biologicals
- Country
- Belgium (BE)
- ATC code
- J07AG51
- ATC class
- Haemophilus Influenzae B, Kombinationen mit Toxoiden
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AG51
Haemophilus influenzae b, kombinationen mit toxoiden, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba604790-1b0c-41a1-bb8a-f9222bebd164 GET /v1/drugs/ba604790-1b0c-41a1-bb8a-f9222bebd164?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and suspension for suspension for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Infanrix+Hib 0,5 ml/dose",
"name_fr": "Infanrix+Hib 0,5 ml/dose",
"name_nl": "Infanrix+Hib 0,5 ml/dose",
"amp_code": "SAM193995-00",
"strengths": [
"25.0000",
"8.0000",
"30.0000",
"8.0000",
"25.0000",
"40.0000",
"25.0000",
"30.0000",
"30.0000",
"25.0000",
"30.0000",
"40.0000"
],
"pack_count": 2,
"substances": [
"Bordetella Pertussis Filamentous Hemagglutinin (FHA)",
"Bordetella Pertussis Pertactin",
"Diphtheria Toxoid (DT)",
"Bordetella Pertussis Toxoid (PT)",
"Tetanus Toxoid",
"Conjugate of Haemophilus influenzae type b capsular polysaccharide and Tetanus toxoid",
"Lactose",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Haemophilus Influenzae B, Combinations with Toxoids",
"authorisation_numbers": [
"BE193995",
"BE194013"
]
}See everything about haemophilus influenzae b, kombinationen mit toxoiden.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.